SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001117480-22-000019
Filing Date
2022-05-16
Accepted
2022-05-16 07:07:49
Documents
16
Period of Report
2022-05-16
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cmrx-20220516.htm   iXBRL 8-K 44371
5 EX-99.1 exhibit99120220331cmrxearn.htm EX-99.1 91675
6 EX-99.2 exhibit99220220331cmrxemer.htm EX-99.2 12231
7 chimerixlogoa02.jpg GRAPHIC 13737
8 image_0a.jpg GRAPHIC 9471
  Complete submission text file 0001117480-22-000019.txt   332560

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cmrx-20220516.xsd EX-101.SCH 1902
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cmrx-20220516_lab.xml EX-101.LAB 24849
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cmrx-20220516_pre.xml EX-101.PRE 13046
10 EXTRACTED XBRL INSTANCE DOCUMENT cmrx-20220516_htm.xml XML 11819
Mailing Address 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713
Business Address 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713 919.806.1074
CHIMERIX INC (Filer) CIK: 0001117480 (see all company filings)

IRS No.: 330903395 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35867 | Film No.: 22925397
SIC: 2834 Pharmaceutical Preparations